In Vitro Diagnostics (IVD) News: Breaking In Vitro Diagnostics (IVD) News, Comments and Articles. - Page: 5

13:19 EST 18th December 2014 | BioPortfolio

In Vitro Diagnostics (IVD) News - Page: 5Twitter RSS

Read the latest In Vitro Diagnostics (IVD) News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on In Vitro Diagnostics (IVD).

Search or Follow Our In Vitro Diagnostics (IVD) - Page: 5 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More In Vitro Diagnostics (IVD) - Page: 5 News.
You can also follow our In Vitro Diagnostics (IVD) - Page: 5 news stories on Twitter: @IVDiagnostics

Showing "invitro diagnostics vitro" News Articles 101 to 125 of 4,200+

Monday 15th December 2014

AvanSci sells Roche its tissue microdissection system

Roche Diagnostics Corp. acquired AvanSci Bio LLC’s high-performance tissue microdissection system. The transaction includes the MilliSect automated instrumentation, along with software and consumables.

Bioventus Receives Award from Human Factors and Ergonomics Society

Bioventus, a global leader in orthobiologic solutions, today announced it received an award for its next generation EXOGEN® Ultrasound Bone Healing System at the Human Factors and Ergonomics Society (HFES) International Annual Meeting on October 28 in Chicago. Recog

Potential New Tool for Cervical Cancer Detection and Diagnosis

Researchers in Changsha, China demonstrate in the laboratory that photoacoustic imaging has the potential to be used as a quicker, cheaper and non-invasive method to detect and stage cervical cancer Cervical cancer is, in many ways, a shining example of how successful the war on cancer can be. Thanks largely to the advent of Pap smear screening, U.S. c...

Lawmakers Seek Input On Dx Regs, With Lab-Developed Tests In Focus

The House Energy and Commerce Committee is seeking feedback on initiatives Congress should enact in 2015 regarding regulation of diagnostics, and in particular in response to FDA's plan to regulate laboratory developed tests.

Rei Lopez Joins Aurora Diagnostics as Vice President of Hospital Operations

Aurora Diagnostics announced today that Rei Lopez will join the company as Vice President of Hospital Operations. In this role, Mr. Lopez will focus on supporting and expanding Aurora’s hospital partnerships. Aurora is a leading national provider of pathology lab management and staffing services for hospitals, and the Company views this as an important g...

Ortho-Clinical Diagnostics, Inc. Introduces the Astute NEPHROCHECK® Test System, A First of its Kind Test to Assess Risk for Acute Kidney Injury

-Early knowledge of AKI risk may prompt closer patient monitoring and help prevent permanent kidney damage or death- Ortho-Clinical Diagnostics, Inc. today announced the nationwide availability to hospitals of the NEPHROCHECK® Test System designed to help healthcare providers identify patients at risk of developing moderate or severe acute kidney inju...

Seattle Researchers are a Significant Step Closer to an HIV Vaccine

Research team finds a vaccine candidate that stimulates the production of neutralizing antibodies that defend against infection from a broad spectrum of HIV strains A team of researchers have discovered a vaccine candidate that is expected to stimulate the production of neutralizing antibodies that defend against infection from a broad spectrum of HIV ...

The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 9th Edition

        LONDON, Dec. 15, 2014 /PRNewswire/ -- In nine best-selling editions, Shara Rosen (MBA, RT), has created authoritative market estimates and forecasted growth models for in vitro diagnostic (IVD) testing products throughout the world. This single volume covers the entirety of the clinical testing market and all of its segments, providing customers with a ...

Companion Diagnostics Market byTechnology (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry), Application (Breast, Lung cancer), & by End-user (Pharmaceutical Companies, Reference Lab)] - Global Trends & Forecasts to 2019

    LONDON, Dec. 15, 2014 /PRNewswire/ -- The global companion diagnostics market is expected to grow at a CAGR of 22.7% from 2014 to 2019. Factors such as rising need for personalized medicine in cancer treatment, growing adoption of companion diagnostics by the pharmaceutical industry, support from regulatory authorities, and emerging technologies such as next-generation...

OPKO, Pfizer ink global agreement for human growth hormone

OPKO Health, a multinational biopharmaceutical and diagnostics company, and Pfizer have entered into a worldwide agreement for the development and commercialization of OPKO's long-acting hGH-CTP for the treatment of growth hormone deficiency (GHD) i...

Bill & Melinda Gates Foundation awards grant to Fio for Ebola diagnostics

Fio has received a grant financed by the Bill & Melinda Gates Foundation to adapt its Fionet solution to connect rapid diagnostics and data in the fight against Ebola. Headquartered in Toronto, Canada, Fio's solution combines mobile intelligent dev...

California Joint Powers Insurance Authority Selects Harbor One MPN as Their Medical Provider Network

California JPIA Members Can Achieve Lower Costs, Reduced Litigation, and Use of Innovative “Care Concierge” Service The California Joint Powers Insurance Authority (California JPIA) has selected the Harbor One℠ MPN for their medical provider network needs.

Ignyta Announces Amendment to License Agreement with Nerviano

Ignyta, Inc. (Nasdaq: RXDX), a precision oncology biotechnology company, today announced that it has entered into an amendment to its license agreement with Nerviano Medical Sciences, S.r.l. relating to its entrectinib (formerly RXDX-101) product candidate. The amendment modifies the milestones that would trigger the initial three milestone payments speci...

Bruker Introduces BioScope Resolve High-Resolution BioAFM System

Featuring PeakForce Tapping for Quantitative Bio-Mechanical Property Mapping At the Sixth AFM BioMed Conference, Bruker (NASDAQ: BRKR) today announced the release of BioScope Resolve™, a biological atomic force microscope (bioAFM) that features the highest resolution imaging and most complete

SQI Diagnostics Wins Additional Business from UK-based Customer

Technology Transfer Agreement Signals Revenue Growth Opportunities TORONTO, Dec 15, 2014 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; OTCQX: SQIDF) today announced that it has advanced its existing commercial relationship with a UK-based customer, enabling the Company to manufacture a 19-plex infectious disease, DNA-based test in its state-of-the-...

MP Biomedicals receives FDA approval for HTLV confirmatory assay

MP Biomedicals, a leading provider of life science reagents, fine chemicals and diagnostic products, announced today that it has received FDA approval on the MP Diagnostics HTLV (Human T-Cell Lymphotropic Virus) Blot 2.4, a Western Blot for HTLV conf...

Abbott Commences Tender Offer and Consent Solicitation for CFR International SpA 5.125% Senior Notes due 2022

ABBOTT PARK, Ill., Dec. 15, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that its wholly-owned subsidiary, Abbott Laboratories (Chile) Holdco (Dos) SpA, a Chilean corporation ("ALH"), has commenced a tender offer (the "U.S. Notes Offer"), in which it is offering to purchase for cash any and all of the outstanding $300 million aggregate principal amount of 5.125% Senior Notes due 2022 (t...

2020 Global Sheep Placenta Extract Market Development Trends & Analysis Now Available at LifeScienceIndustryResearch.com

LifeScienceIndustryResearch.com adds a report “2014 Deep Research Report on Global Sheep Placenta Extract Industry” to its research Store. Dallas, Texas (PRWEB) December 15, 2014 2014 Deep Research Report on Global Sheep Placenta Extract Industry is a professional and in-depth research report. The report provides information such as Sheep Placenta Extract definition, classification, applicati...

FDA approves HTLV confirmatory assay for blood screening

MP Biomedicals has received FDA approval for its MP Diagnostics HTLV Blot 2.4, an enzyme immunoassay that differentiates betw -More- 

Aptose Biosciences Announces Appointment of Dr. Erich Platzer to Board of Directors

Adds Commercial Expertise to Board SAN DIEGO and TORONTO, Dec. 15, 2014 /PRNewswire/ - Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS), a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer, today announced the appointment of Dr. Erich M. Platzer, oncology industry veteran and venture investor, to the Board of Direct...

FDAnews Announces: 12th Annual Medical Device Quality Congress, March 17-19, 2015

Over the past 11 years, thousands of device professionals have attended Medical Device Quality Congress (MDQC) and benefited from the unmatched educational sessions presented by FDA officials and industry experts. For 2015, FDAnews has crafted a groundbreaking three-day agenda that will provide a thorough overview of all the key issues confronting device makers, diagnostics makers, LDT developers...

Synageva BioPharma Announces Active Investigational New Drug Application For SBC-103 For The Treatment Of Mucopolysaccharidosis IIIB

LEXINGTON, Mass., Dec. 15, 2014 /PRNewswire/ -- Synageva BioPharma Corp. (NASDAQ: GEVA), a biopharmaceutical company developing therapeutic products for rare disorders, announced today that the investigational new drug (IND) application to the U.S. Food & Drug Administration (FDA) to evaluate SBC-103 as a treatment for mucopolysaccharidosis IIIB (MPS IIIB, also known as Sanfilippo B syndr...

Sunday 14th December 2014

Stunning zinc fireworks when egg meets sperm

(Northwestern University) Sparks literally fly when a sperm and an egg hit it off. The fertilized mammalian egg releases from its surface billions of zinc atoms in 'zinc sparks,' one wave after another, a Northwestern University-led research team has...

Biocept, Inc. Expands Worldwide Microchannel Patent Protection To South Korea

SAN DIEGO, Dec. 15, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) biomarker analysis, today announced that it has been granted a patent in South Korea for its fluidic microfluidic...

Spectral Announces Normal Course Issuer Bid

TORONTO, ONTARIO -- (Marketwired) -- 12/15/14 -- Spectral Diagnostics Inc. ("Spectral" or the "Company") (TSX: SDI)(OTCQX: DIAGF) a Phase III company developing the first theranostic treatment for patients with septic shock, today announced that the Toronto Stock Exchange ("TSX") has accepted Spectral's notice of intention to proceed with a normal course issuer bid through the facilities of the ...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks